In this work, the molecular and phenotypic antimicrobial resistance and clonal diversity of 10 linezolid-resistant Staphylococcus spp. isolates were investigated. The 7 Staphylococcus haemolyticus isolates presented Staphylococcal cassete chromosome mec (SCCmec) V and belonged to the same pulsed-field gel electrophoresis pulsotype. Their MICs for oxacillin, vancomycin, and linezolid were ≥ 256 μg/mL, 1-4 μg/mL, and 8-16 μg/mL, respectively. The 3 S. hominis presented MIC values 32 to >256 μg/mL, 2-4 μg/mL, and 12-24 μg/mL, and all carried the nontypeable SCCmec (ccr1 + mecA class) and belonged to 2 different genotypes. The cfr gene was not found, but the mutation G2603T was detected in S. haemolyticus and C2190T and G2603T in Staphylococcus hominis in 23S rRNA. This study demonstrates the spread of a linezolid-resistant S. haemolyticus genotype and, for the first time, describes the mutation C2190T among S. hominis isolates with a double mutation in Brazil.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.diagmicrobio.2014.09.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acetylshikonin Derived From Arnebia euchroma (Royle) Johnst Kills Multidrug-Resistant Gram-Positive Pathogens In Vitro and In Vivo.
Phytother Res
January 2025
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
The rising prevalence of multidrug-resistant (MDR) Gram-positive bacteria threatens the effectiveness of current antibiotic therapies. However, the development of new antibiotics has stagnated in recent years, highlighted the critical need for the discovery of innovative antimicrobial agents. This study aims to evaluate the antibacterial activity of naphthoquinones derived from Arnebia euchroma (Royle) Johnst (ADNs) and elucidate their underlying mechanisms.
View Article and Find Full Text PDFPharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulation.
J Glob Antimicrob Resist
November 2024
Department of Hematology, Tianjin First Central Hospital, Tianjin, PR China.
Objective: The objective of this study was to investigate the cumulative fraction of response of various dosage regimens of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults.
Methods: Monte Carlo simulations were performed using previously published pharmacokinetic parameters and pharmacodynamic data to evaluate the efficacy of the simulated dosage strategies in terms of area under the concentration-time curve/minimum inhibitory concentration targets of tedizolid.
Results: According to the results of the Monte Carlo simulations, currently approved dosage regimens of tedizolid phosphate were effective in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by methicillin-susceptible S.
Dalbavancin-resistant selection following a prosthetic joint infection: phenotypic and genomic characterization.
JAC Antimicrob Resist
October 2024
Institut de Biologie des Hôpitaux de Nantes, Service de Bactériologie et des Contrôles Microbiologiques, CHU de Nantes, 9 quai Moncousu, 44093 Nantes Cedex 01, France.
Background: Dalbavancin is a lipoglycopeptide antibiotic with a wide spectrum of activity against Gram-positive bacteria, including MDR isolates. Its pharmacokinetic properties and administration patterns could be useful for the treatment of bone and joint infections, especially prosthetic joint infections (PJIs).
Introduction: We report the case of an 80-year-old man who experienced an acute periprosthetic joint infection of his right total knee arthroplasty (TKA).
Investigation of a linezolid-resistant outbreak in a French hospital: phenotypic, genotypic, and clinical characterization.
Front Microbiol
September 2024
Service de Bactériologie-Virologie-Hygiène, Centre Hospitalier Universitaire de Tours, Tours, France.
Article Synopsis
- A study was conducted at Tours University Hospital to investigate an outbreak of linezolid-resistant strains of bacteria (LRSE) from 2017 to 2021, focusing on their resistance mechanisms and transmission routes.
- Out of 34 LRSE isolates, 20 were analyzed, revealing high resistance to linezolid linked to a specific genetic mutation, with most strains being closely genetically related (95% similarity).
- The findings suggest that prior use of linezolid may have contributed to the outbreak, and hand-to-hand transmission by healthcare workers could have played a role; the study also evaluated a new typing method, IR-Biotyper, which showed promise for future use.
Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus.
J Antimicrob Chemother
December 2024
Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing Dongcheng District, 100730, Beijing, China.
Article Synopsis
- A multicenter study across 65 hospitals in China analyzed the effectiveness of contezolid against various strains of Staphylococcus and Enterococcus, focusing on its susceptibility and resistance patterns.
- The research found that all strains were susceptible to contezolid, with low resistance rates to other antibiotics, notably finding higher linezolid resistance in Enterococcus faecalis than in Enterococcus faecium.
- Results showed contezolid had a lower MIC50 compared to linezolid, indicating it may be a more effective option against resistant bacterial strains, particularly methicillin-resistant Staphylococcus and linezolid-resistant E. faecalis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!